CoChat

EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis

Open access
Wang, Jun, Yu, Xufen, Gong, Weida, Liu, Xijuan, Park, Kwang-Su, Ma, Anqi, Tsai, Yi-Hsuan, Shen, Yudao, Onikubo, Takashi, Pi, Wen-Chieh, Allison, David F., Liu, Jing, Chen, Wei-Yi, Cai, Ling, Roeder, Robert G., Jin, Jian, Wang, Gang Greg · 2022 · Nature Cell Biology
Cited by 181

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Canonically, EZH2 serves as the catalytic subunit of PRC2, which mediates H3K27me3 deposition and transcriptional repression. Here, we report that in acute leukaemias, EZH2 has additional noncanonical functions by binding cMyc at non-PRC2 targets and uses a hidden transactivation domain (TAD) for (co)activator recruitment and gene activation. Both canonical (EZH2–PRC2) and noncanonical (EZH2-TAD–cMyc–coactivators) activities of EZH2 promote oncogenesis, which explains the slow and ineffective antitumour effect of inhibitors of the catalytic function of EZH2. To suppress the multifaceted activities of EZH2, we used proteolysis-targeting chimera (PROTAC) to develop a degrader, MS177, which achieved effective, on-target depletion of EZH2 and interacting partners (that is, both canonical EZH2–PRC2 and noncanonical EZH2–cMyc complexes). Compared with inhibitors of the enzymatic function of EZH2, MS177 is fast-acting and more potent in suppressing cancer growth. This study reveals noncanonical oncogenic roles of EZH2, reports a PROTAC for targeting the multifaceted tumorigenic functions of EZH2 and presents an attractive strategy for treating EZH2-dependent cancers. Wang et al. reveal a noncanonical mechanism for EZH2 in binding the oncoprotein cMyc to promote tumorigenesis, and develop a small-molecule degrader, MS177, to target both canonical and noncanonical functions of EZH2 to suppress tumour growth.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41556-022-00850-x

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 181

Metadata

Authors
Wang, J., Yu, X., Gong, W., Liu, X., Park, K.-S., Ma, A., Tsai, Y.-H., Shen, Y., Onikubo, T., Pi, W.-C., Allison, D. F., Liu, J., Chen, W.-Y., Cai, L., Roeder, R. G., Jin, J., & Wang, G. G.
Venue
Nature Cell Biology
Published
2022-02-24
Volume
24
Issue
3
Pages
384-399
ISSN
  • 1465-7392 (ISSN-L)
  • 1476-4679
OpenAlex
W4213439903
Cited by
181
References
22
FWCI
11.05
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis. https://app.cochat.ai/papers/10.1038/s41556-022-00850-x
The paper
Wang, J., Yu, X., Gong, W., Liu, X., Park, K.-S., Ma, A., Tsai, Y.-H., Shen, Y., Onikubo, T., Pi, W.-C., Allison, D. F., Liu, J., Chen, W.-Y., Cai, L., Roeder, R. G., Jin, J., & Wang, G. G. (2022). EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis. Nature Cell Biology. https://doi.org/10.1038/s41556-022-00850-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.